Search Results - "Rios, Rafael S"

Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis by Lu, Feng‐Bin, Zheng, Kenneth I, Rios, Rafael S, Targher, Giovanni, Byrne, Christopher D, Zheng, Ming‐Hua

“…Background and Aim Lean non‐alcoholic fatty liver disease (NAFLD) is a potentially metabolically unhealthy state that refers to NAFLD occurring in…”
Get full text

COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies by Feng, Gong, Zheng, Kenneth I, Yan, Qin-Qin, Rios, Rafael S, Targher, Giovanni, Byrne, Christopher D, Poucke, Sven Van, Liu, Wen-Yue, Zheng, Ming-Hua

“…The outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has attracted increasing…”
Get full text

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma by Rios, Rafael S., Zheng, Kenneth I., Zheng, Ming-Hua

“…The emergence of non-alcoholic fatty liver disease (NAFLD) as the leading chronic liver disease worldwide raises some concerns. In particular, NAFLD is closely…”
Get full text

Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy‐confirmed NAFLD by Feng, Gong, Zheng, Kenneth I., Li, Yang‐Yang, Rios, Rafael S., Zhu, Pei‐Wu, Pan, Xiao‐Yan, Li, Gang, Ma, Hong‐Lei, Tang, Liang‐Jie, Byrne, Christopher D., Targher, Giovanni, He, Na, Mi, Man, Chen, Yong‐Ping, Zheng, Ming‐Hua

“…Background The presence of significant liver fibrosis is a key determinant of long‐term prognosis in non‐alcoholic fatty liver disease (NAFLD). We aimed to…”
Get full text

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease by Rios, Rafael S., Zheng, Kenneth I., Targher, Giovanni, Byrne, Christopher D., Zheng, Ming-Hua

“…[3] Although the current “gold standard” for staging liver fibrosis is the liver biopsy, the invasive nature of this method limits its utility in routine…”
Get full text

Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study by Zhang, Huai, Rios, Rafael S., Boursier, Jerome, Anty, Rodolphe, Chan, Wah-Kheong, George, Jacob, Yilmaz, Yusuf, Wong, Vincent Wai-Sun, Fan, Jiangao, Dufour, Jean-François, Papatheodoridis, George, Chen, Li, Schattenberg, Jörn M., Shi, Junping, Xu, Liang, Wong, Grace Lai-Hung, Lange, Naomi F., Papatheodoridi, Margarita, Mi, Yuqiang, Zhou, Yujie, Byrne, Christopher D., Targher, Giovanni, Feng, Gong, Zheng, Minghua

“…Liver biopsy for the diagnosis of non-alcoholic steatohepatitis (NASH) is limited by its inherent invasiveness and possible sampling errors. Some studies have…”
Get full text

Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients by Liu, Wen-Yue, Zhang, Xiaofang, Li, Gang, Tang, Liang-Jie, Zhu, Pei-Wu, Rios, Rafael S, Zheng, Kenneth I, Ma, Hong-Lei, Wang, Xiao-Dong, Pan, Qiuwei, de Knegt, Robert J, Valenti, Luca, Ghanbari, Mohsen, Zheng, Ming-Hua

“…Non-alcoholic fatty liver disease (NAFLD) is closely associated with metabolic dysfunction. Among the multiple factors, genetic variation acts as important…”
Get full text

Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis by Ma, Hong-Lei, Zheng, Kenneth I, Rios, Rafael S, Tang, Liang-Jie, Li, Gang, Zhu, Pei-Wu, Wang, Xiao-Dong, Chen, Yong-Ping, Zheng, Ming-Hua

“…Caspase-cleaved K18 (cK18) may accurately reflect hepatocyte apoptosis in patients with non-alcoholic steatohepatitis (NASH). However, NASH can also exist…”
Get full text

COVID-19 Cross-Infection and Pressured Ulceration Among Healthcare Workers: Are We Really Protected by Respirators? by Zheng, Kenneth I., Rios, Rafael S., Zeng, Qi-Qiang, Zheng, Ming-Hua

Get full text

MAFLD and risk of CKD by Sun, Dan-Qin, Jin, Yan, Wang, Ting-Yao, Zheng, Kenneth I., Rios, Rafael S., Zhang, Hao-Yang, Targher, Giovanni, Byrne, Christopher D., Yuan, Wei-Jie, Zheng, Ming-Hua

“…Whereas nonalcoholic fatty liver disease (NAFLD) is a multisystem disease, the association between metabolic dysfunction-associated fatty liver disease (MAFLD)…”
Get full text

Data sharing during COVID-19 pandemic: what to take away by Rios, Rafael S, Zheng, Kenneth I, Zheng, Ming-Hua

“…In light of the viral outbreak of SARS-CoV-2 that monopolized the focus of the scientific community and general public alike for the past 6 months, one of the…”
Get more information

Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease by Li, Gang, Rios, Rafael S., Wang, Xin-Xin, Yu, Yue, Zheng, Kenneth I., Huang, Ou-Yang, Tang, Liang-Jie, Ma, Hong-Lei, Jin, Yi, Targher, Giovanni, Byrne, Christopher D., Pan, Xiao-Yan, Zheng, Ming-Hua

“…Sarcopenic obesity is regarded as a risk factor for the progression and development of non-alcoholic fatty liver disease (NAFLD). Since male sex is a risk…”
Get full text

Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease by Liu, Wen‐Yue, Zheng, Kenneth I., Pan, Xiao‐Yan, Ma, Hong‐Lei, Zhu, Pei‐Wu, Wu, Xi‐Xi, Rios, Rafael S., Targher, Giovanni, Byrne, Christopher D, Wang, Xiao‐Dong, Chen, Yong‐Ping, Zheng, Ming‐Hua

“…Background and Aim Patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) I148M (rs738409) genotype influences clinical/biochemical characteristics in…”
Get full text

Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease by Zhu, Sheng-Hao, Zheng, Kenneth I., Hu, Di-Shuang, Gao, Feng, Rios, Rafael S., Li, Gang, Li, Yang-Yang, Byrne, Christopher D., Targher, Giovanni, Chen, Yong-Ping, Zheng, Ming-Hua

“…OBJECTIVEFibroTouch is a newly developed device to assess ultrasound attenuation parameter (UAP) and liver stiffness measurement to quantify hepatic steatosis…”
Get full text

FNDC5 polymorphism influences the association between sarcopenia and liver fibrosis in adults with biopsy-proven non-alcoholic fatty liver disease by Gao, Feng, Zheng, Kenneth I., Zhu, Pei-Wu, Li, Yang-Yang, Ma, Hong-Lei, Li, Gang, Tang, Liang-Jie, Rios, Rafael S., Liu, Wen-Yue, Pan, Xiao-Yan, Targher, Giovanni, Byrne, Christopher D., Chen, Yong-Ping, Zheng, Ming-Hua

“…The FNDC5 gene encodes the fibronectin type III domain-containing protein 5 that is a membrane protein mainly expressed in skeletal muscle, and the FNDC5…”
Get full text

J-shaped relationship between serum zinc levels and the severity of hepatic necro-inflammation in patients with MAFLD by Chen, Sui-Dan, Zhang, Huai, Rios, Rafael S., Li, Yang-Yang, Zhu, Pei-Wu, Jin, Yi, Ma, Hong-Lei, Tang, Liang-Jie, Li, Gang, Huang, Ou-Yang, Zheng, Kenneth I., Byrne, Christopher D., Targher, Giovanni, Zheng, Ming-Hua

“…Zinc is an essential trace element that plays an important role in maintaining health, and affecting gene expression, signal transduction and regulation of…”
Get full text

TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy‐proven nonalcoholic fatty liver disease by Ma, Hong‐Lei, Chen, Sui‐Dan, Zheng, Kenneth I, Yu, Yue, Wang, Xin‐Xin, Tang, Liang‐Jie, Li, Gang, Rios, Rafael S, Huang, Ou‐Yang, Zheng, Xiao‐Yong, Xu, Ren‐Ai, Targher, Giovanni, Byrne, Christopher D, Wang, Xiao‐Dong, Chen, Yong‐Ping, Zheng, Ming‐Hua

“…Background and Aim Cytochrome P450 2E1 (CYP2E1) plays a role in lipid metabolism, and by increasing hepatic oxidative stress and inflammation, the upregulation…”
Get full text

Recommendations and Clinical Guidance for Children with Metabolic-associated Fatty Liver Disease during the COVID-19 Pandemic by Zhou, Yong-Hai, Rios, Rafael S, Zheng, Kenneth I, Zheng, Ming-Hua

Get full text

A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study by Chen, Zhong-Wei, Xiao, Huan-Ming, Ye, Xinjian, Liu, Kun, Rios, Rafael S., Zheng, Kenneth I., Jin, Yi, Targher, Giovanni, Byrne, Christopher D., Shi, Junping, Yan, Zhihan, Chi, Xiao-Ling, Zheng, Ming-Hua

Get full text

LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis by Li, Gang, Zheng, Tian-Lei, Chi, Xiao-Ling, Zhu, Yong-Fen, Chen, Jin-Jun, Xu, Liang, Shi, Jun-Ping, Wang, Xiao-Dong, Zhao, Wei-Guo, Byrne, Christopher D., Targher, Giovanni, Rios, Rafael S., Huang, Ou-Yang, Tang, Liang-Jie, Zhang, Shi-Jin, Geng, Shi, Xiao, Huan-Ming, Chen, Sui-Dan, Zhang, Rui, Zheng, Ming-Hua

Get full text